SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

18 May 2022 Evaluate
The revenue zoomed 16.80% to Rs. 9128.48 millions for the quarter ended March 2022 as compared to Rs. 7815.51 millions during the corresponding quarter last year.Net profit declined -9.14% to Rs. 1292.44 millions from Rs. 1422.53 millions.A decline of 2102.48 millions was observed in the OP in the quarter ended March 2022 from 2259.76 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 9128.48 7815.51 16.80 32384.37 31349.82 3.30 32384.37 31349.82 3.30
Other Income 42.79 30.61 39.79 175.10 137.23 27.60 175.10 137.23 27.60
PBIDT 2102.48 2259.76 -6.96 6621.59 8750.96 -24.33 6621.59 8750.96 -24.33
Interest 40.01 57.53 -30.45 163.52 237.74 -31.22 163.52 237.74 -31.22
PBDT 2062.47 2202.23 -6.35 6458.07 8513.22 -24.14 6458.07 8513.22 -24.14
Depreciation 316.83 305.11 3.84 1261.61 1184.51 6.51 1261.61 1184.51 6.51
PBT 1745.64 1897.12 -7.98 5196.46 7328.71 -29.09 5196.46 7328.71 -29.09
TAX 453.20 474.59 -4.51 1331.31 1800.87 -26.07 1331.31 1800.87 -26.07
Deferred Tax 11.44 6.46 77.09 -3.76 -169.74 -97.78 -3.76 -169.74 -97.78
PAT 1292.44 1422.53 -9.14 3865.15 5527.84 -30.08 3865.15 5527.84 -30.08
Equity 248.01 247.68 0.13 248.01 247.68 0.13 248.01 247.68 0.13
PBIDTM(%) 23.03 28.91 -20.34 20.45 27.91 -26.75 20.45 27.91 -26.75

Granules India Share Price

675.25 20.85 (3.19%)
20-Apr-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1676.05
Dr. Reddys Lab 1237.50
Cipla 1239.40
Zydus Lifesciences 942.20
Lupin 2327.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×